NDC 71384-510

Triamcinolone-Moxifloxacin PF

Triamcinolone-moxifloxacin Pf

Triamcinolone-Moxifloxacin PF is a Ophthalmic Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Imprimis Njof, Llc. The primary component is Triamcinolone Acetonide; Moxifloxacin Hydrochloride Monohydrate.

Product ID71384-510_638a4320-9c17-4122-e053-2991aa0af758
NDC71384-510
Product TypeHuman Prescription Drug
Proprietary NameTriamcinolone-Moxifloxacin PF
Generic NameTriamcinolone-moxifloxacin Pf
Dosage FormInjection, Suspension
Route of AdministrationOPHTHALMIC
Marketing Start Date2018-01-05
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameImprimis NJOF, LLC
Substance NameTRIAMCINOLONE ACETONIDE; MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATE
Active Ingredient Strength15 mg/mL; mg/mL
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Quinolone Antimicrobial [EPC],Quinolones [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 71384-510-01

20 VIAL, SINGLE-USE in 1 BOX (71384-510-01) > .6 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2018-01-05
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71384-510-01 [71384051001]

Triamcinolone-Moxifloxacin PF INJECTION, SUSPENSION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-01-05
Inactivation Date2020-01-31
Reactivation Date2020-02-10

Drug Details

Active Ingredients

IngredientStrength
TRIAMCINOLONE ACETONIDE15 mg/mL

OpenFDA Data

SPL SET ID:62fce8cd-0956-2830-e053-2991aa0a041c
Manufacturer
UNII

Pharmacological Class

  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Quinolone Antimicrobial [EPC]
  • Quinolones [CS]

NDC Crossover Matching brand name "Triamcinolone-Moxifloxacin PF" or generic name "Triamcinolone-moxifloxacin Pf"

NDCBrand NameGeneric Name
70261-510Triamcinolone-Moxifloxacin PFTriamcinolone-Moxifloxacin PF
71384-510Triamcinolone-Moxifloxacin PFTriamcinolone-Moxifloxacin PF

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.